Literature DB >> 26768561

A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.

Marco Cavaleri1, Andrew Thomson2, Tomas Salmonson3, Robert J Hemmings4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26768561     DOI： 10.1177/1740774515619860

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  2 in total

1.  First vaccine approval under the FDA Animal Rule.

Authors:  David W C Beasley; Trevor L Brasel; Jason E Comer
Journal:  NPJ Vaccines       Date:  2016-08-25       Impact factor: 7.344

2.  Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.

Authors:  Louise Sigfrid; Katherine Maskell; Peter G Bannister; Sharif A Ismail; Shelui Collinson; Sadie Regmi; Claire Blackmore; Eli Harriss; Kajsa-Stina Longuere; Nina Gobat; Peter Horby; Mike Clarke; Gail Carson
Journal:  BMC Med       Date:  2020-06-25       Impact factor: 8.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.